Authors: P. Jílek 1; J. Špaček 2; V. Buchta 1,4; Z. Kučera 1; M. Drahošová 3; M. Főrstl 4; C. Andrýs 3 Authors‘ workplace: Katedra biologických a lékařských věd, Farmaceutická fakulta UK v Hradci Králové, vedoucí doc. RNDr. V. Semecký, CSc. 1; Porodnická a gynekologická klinika, FN a LF UK v Hradci Králové, přednosta doc. MUDr. J. Tošner, CSc. 2; Ústav klinické imunologie a alergologie, FN a LF UK v Hradci Králové, přednosta MUDr. O. Kopecký, CSc. 3; Ústav klinické mikrobiologie, FN a LF UK v Hradci Králové, přednosta prof. MUDr. M. Špliňo, DrSc. 4 Published in: Ceska Gynekol 2005; 70(6): 453-459 Category: Original Article
Objective: This study was undertaken to characterize systemic immunity in the patients with recurrent vulvovaginal candidiasis.
Subject: original prospective study.
Setting: 1. Department of Biological and Medical sciences, Charles University in Prague, Faculty of Pharmacy, Hradec Kralove, 2. Department of Obstetrics and Gynaecology, Medical Faculty, Hradec Kralove, Charles University in Prague, 3. Department of Clinical Immunology and Allergology, University Hospital, Hradec Kralove, 4. Department of Clinical Microbiology, University Hospital, Hradec Kralove, Czech republic.
Subject and method: Basic immunological parameters in 44 patients with recurrent vulvovaginal candidiasis were investigated and analyzed in this longitudinal follow-up study.
Conclusion: Although there is no fundamental disturbance in systemic immunity in patients with recurrent vulvovaginal candidiasis and the majority of systemic immunological parameters in the patients were within normal range, some subtle changes of a few parameters of humoral and cellular immunity in contrast to the controls were identified.
Key words: recurrent vulvovaginal candidiasis, humoral immunity, cell immunity
Don‘t have an account? Create new account
Enter the email address that you registered with. We will send you instructions on how to set a new password.
